(SCHG) Schwab U.S. Large-Cap Growth - Overview
Etf: Technology, Healthcare, Consumer, Communication, Industrials
Dividends
| Dividend Yield | 0.39% |
| Yield on Cost 5y | 0.71% |
| Yield CAGR 5y | -35.90% |
| Payout Consistency | 96.7% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 25.2% |
| Relative Tail Risk | 4.74% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.23 |
| Alpha | -8.32 |
| Character TTM | |
|---|---|
| Beta | 1.164 |
| Beta Downside | 1.129 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.39% |
| CAGR/Max DD | 1.11 |
Description: SCHG Schwab U.S. Large-Cap Growth January 29, 2026
Schwab’s U.S. Large-Cap Growth ETF (NYSE ARCA: SCHG) seeks to track the Dow Jones U.S. Large-Cap Growth Total Stock Market Index, which selects the 750 largest U.S. stocks that meet growth-oriented criteria (e.g., higher price-to-earnings multiples and earnings-growth expectations). The fund therefore provides exposure to the growth segment of the broad U.S. market while maintaining a large-cap focus.
As of the most recent filing (12 Feb 2026), SCHG holds roughly $31 billion in assets under management, charges an expense ratio of 0.04 %, and its top ten holdings account for about 38 % of the portfolio, led by Apple (AAPL), Microsoft (MSFT), Amazon (AMZN), Alphabet Class A (GOOGL), and Nvidia (NVDA). Sector weights are heavily tilted toward technology (~ 52 %), followed by consumer discretionary (~ 18 %) and health care (~ 12 %). Recent performance shows a year-to-date return of +9.6 % versus the S&P 500’s +7.4 % over the same period, reflecting continued investor appetite for growth stocks despite a higher-for-longer interest-rate environment that typically penalizes valuation-sensitive sectors.
For a deeper dive into how SCHG’s growth exposure aligns with macro-level drivers such as U.S. GDP growth forecasts and the ongoing AI-cloud investment cycle, consider exploring the analytical tools on ValueRay.
What is the price of SCHG shares?
Over the past week, the price has changed by -5.52%, over one month by -6.94%, over three months by -7.61% and over the past year by +6.96%.
Is SCHG a buy, sell or hold?
What are the forecasts/targets for the SCHG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 35.9 | 17.9% |
SCHG Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 52.86b USD (52.86b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 52.86b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 52.86b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.20% (E(52.86b)/V(52.86b) * Re(10.20%) + (debt-free company))
Discount Rate = 10.20% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)